Federal government stores of a key COVID-19 antibody drug, a key weapon to keep the infected out of hospital, are expected to be used in late August as Pandemic funding is running out,
Biden administration officials have told Congress that government supplies Eli Lilly and Company therapy was the only antibody drug to treat non-hospitalized patients Omicron. found to work against, may end if pandemic funding is not renewed. If current usage momentum continues, the supply may run out before it drops.